Global Dementia and Alzheimer’s Disease Treatment Market Research Report 2024(Status and Outlook)

Global Dementia and Alzheimer’s Disease Treatment Market Research Report 2024(Status and Outlook)



Report Overview:

Alzheimer’s disease is a chronic neurodegenerative disorder which results in gradual degradation of the tissues of the brain. This hampers the normal functioning of the brain and impacts the daily lives of patients.

The Global Dementia and Alzheimer’s Disease Treatment Market Size was estimated at USD 3725.43 million in 2023 and is projected to reach USD 4320.35 million by 2029, exhibiting a CAGR of 2.50% during the forecast period.

This report provides a deep insight into the global Dementia and Alzheimer’s Disease Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Dementia and Alzheimer’s Disease Treatment Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Dementia and Alzheimer’s Disease Treatment market in any manner.

Global Dementia and Alzheimer’s Disease Treatment Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Novartis

Pfizer, Inc.

AbbVie Inc.

Allergan plc

Eli Lilly and Company

F. Hoffmann-La Roche Ltd.

AstraZeneca

Biogen

Eisai Co., Ltd.

INmuneBIO

Market Segmentation (by Type)

Cholinesterase Inhibitors

Memantine

Combination Drugs

Market Segmentation (by Application)

Hospital

Clinic

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Dementia and Alzheimer’s Disease Treatment Market

Overview of the regional outlook of the Dementia and Alzheimer’s Disease Treatment Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Dementia and Alzheimer’s Disease Treatment Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Dementia and Alzheimer’s Disease Treatment
1.2 Key Market Segments
1.2.1 Dementia and Alzheimer’s Disease Treatment Segment by Type
1.2.2 Dementia and Alzheimer’s Disease Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Dementia and Alzheimer’s Disease Treatment Market Overview
2.1 Global Market Overview
2.1.1 Global Dementia and Alzheimer’s Disease Treatment Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Dementia and Alzheimer’s Disease Treatment Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Dementia and Alzheimer’s Disease Treatment Market Competitive Landscape
3.1 Global Dementia and Alzheimer’s Disease Treatment Sales by Manufacturers (2019-2024)
3.2 Global Dementia and Alzheimer’s Disease Treatment Revenue Market Share by Manufacturers (2019-2024)
3.3 Dementia and Alzheimer’s Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Dementia and Alzheimer’s Disease Treatment Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Dementia and Alzheimer’s Disease Treatment Sales Sites, Area Served, Product Type
3.6 Dementia and Alzheimer’s Disease Treatment Market Competitive Situation and Trends
3.6.1 Dementia and Alzheimer’s Disease Treatment Market Concentration Rate
3.6.2 Global 5 and 10 Largest Dementia and Alzheimer’s Disease Treatment Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Dementia and Alzheimer’s Disease Treatment Industry Chain Analysis
4.1 Dementia and Alzheimer’s Disease Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Dementia and Alzheimer’s Disease Treatment Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Dementia and Alzheimer’s Disease Treatment Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Dementia and Alzheimer’s Disease Treatment Sales Market Share by Type (2019-2024)
6.3 Global Dementia and Alzheimer’s Disease Treatment Market Size Market Share by Type (2019-2024)
6.4 Global Dementia and Alzheimer’s Disease Treatment Price by Type (2019-2024)
7 Dementia and Alzheimer’s Disease Treatment Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Dementia and Alzheimer’s Disease Treatment Market Sales by Application (2019-2024)
7.3 Global Dementia and Alzheimer’s Disease Treatment Market Size (M USD) by Application (2019-2024)
7.4 Global Dementia and Alzheimer’s Disease Treatment Sales Growth Rate by Application (2019-2024)
8 Dementia and Alzheimer’s Disease Treatment Market Segmentation by Region
8.1 Global Dementia and Alzheimer’s Disease Treatment Sales by Region
8.1.1 Global Dementia and Alzheimer’s Disease Treatment Sales by Region
8.1.2 Global Dementia and Alzheimer’s Disease Treatment Sales Market Share by Region
8.2 North America
8.2.1 North America Dementia and Alzheimer’s Disease Treatment Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Dementia and Alzheimer’s Disease Treatment Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Dementia and Alzheimer’s Disease Treatment Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Dementia and Alzheimer’s Disease Treatment Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Dementia and Alzheimer’s Disease Treatment Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Novartis
9.1.1 Novartis Dementia and Alzheimer’s Disease Treatment Basic Information
9.1.2 Novartis Dementia and Alzheimer’s Disease Treatment Product Overview
9.1.3 Novartis Dementia and Alzheimer’s Disease Treatment Product Market Performance
9.1.4 Novartis Business Overview
9.1.5 Novartis Dementia and Alzheimer’s Disease Treatment SWOT Analysis
9.1.6 Novartis Recent Developments
9.2 Pfizer, Inc.
9.2.1 Pfizer, Inc. Dementia and Alzheimer’s Disease Treatment Basic Information
9.2.2 Pfizer, Inc. Dementia and Alzheimer’s Disease Treatment Product Overview
9.2.3 Pfizer, Inc. Dementia and Alzheimer’s Disease Treatment Product Market Performance
9.2.4 Pfizer, Inc. Business Overview
9.2.5 Pfizer, Inc. Dementia and Alzheimer’s Disease Treatment SWOT Analysis
9.2.6 Pfizer, Inc. Recent Developments
9.3 AbbVie Inc.
9.3.1 AbbVie Inc. Dementia and Alzheimer’s Disease Treatment Basic Information
9.3.2 AbbVie Inc. Dementia and Alzheimer’s Disease Treatment Product Overview
9.3.3 AbbVie Inc. Dementia and Alzheimer’s Disease Treatment Product Market Performance
9.3.4 AbbVie Inc. Dementia and Alzheimer’s Disease Treatment SWOT Analysis
9.3.5 AbbVie Inc. Business Overview
9.3.6 AbbVie Inc. Recent Developments
9.4 Allergan plc
9.4.1 Allergan plc Dementia and Alzheimer’s Disease Treatment Basic Information
9.4.2 Allergan plc Dementia and Alzheimer’s Disease Treatment Product Overview
9.4.3 Allergan plc Dementia and Alzheimer’s Disease Treatment Product Market Performance
9.4.4 Allergan plc Business Overview
9.4.5 Allergan plc Recent Developments
9.5 Eli Lilly and Company
9.5.1 Eli Lilly and Company Dementia and Alzheimer’s Disease Treatment Basic Information
9.5.2 Eli Lilly and Company Dementia and Alzheimer’s Disease Treatment Product Overview
9.5.3 Eli Lilly and Company Dementia and Alzheimer’s Disease Treatment Product Market Performance
9.5.4 Eli Lilly and Company Business Overview
9.5.5 Eli Lilly and Company Recent Developments
9.6 F. Hoffmann-La Roche Ltd.
9.6.1 F. Hoffmann-La Roche Ltd. Dementia and Alzheimer’s Disease Treatment Basic Information
9.6.2 F. Hoffmann-La Roche Ltd. Dementia and Alzheimer’s Disease Treatment Product Overview
9.6.3 F. Hoffmann-La Roche Ltd. Dementia and Alzheimer’s Disease Treatment Product Market Performance
9.6.4 F. Hoffmann-La Roche Ltd. Business Overview
9.6.5 F. Hoffmann-La Roche Ltd. Recent Developments
9.7 AstraZeneca
9.7.1 AstraZeneca Dementia and Alzheimer’s Disease Treatment Basic Information
9.7.2 AstraZeneca Dementia and Alzheimer’s Disease Treatment Product Overview
9.7.3 AstraZeneca Dementia and Alzheimer’s Disease Treatment Product Market Performance
9.7.4 AstraZeneca Business Overview
9.7.5 AstraZeneca Recent Developments
9.8 Biogen
9.8.1 Biogen Dementia and Alzheimer’s Disease Treatment Basic Information
9.8.2 Biogen Dementia and Alzheimer’s Disease Treatment Product Overview
9.8.3 Biogen Dementia and Alzheimer’s Disease Treatment Product Market Performance
9.8.4 Biogen Business Overview
9.8.5 Biogen Recent Developments
9.9 Eisai Co., Ltd.
9.9.1 Eisai Co., Ltd. Dementia and Alzheimer’s Disease Treatment Basic Information
9.9.2 Eisai Co., Ltd. Dementia and Alzheimer’s Disease Treatment Product Overview
9.9.3 Eisai Co., Ltd. Dementia and Alzheimer’s Disease Treatment Product Market Performance
9.9.4 Eisai Co., Ltd. Business Overview
9.9.5 Eisai Co., Ltd. Recent Developments
9.10 INmuneBIO
9.10.1 INmuneBIO Dementia and Alzheimer’s Disease Treatment Basic Information
9.10.2 INmuneBIO Dementia and Alzheimer’s Disease Treatment Product Overview
9.10.3 INmuneBIO Dementia and Alzheimer’s Disease Treatment Product Market Performance
9.10.4 INmuneBIO Business Overview
9.10.5 INmuneBIO Recent Developments
10 Dementia and Alzheimer’s Disease Treatment Market Forecast by Region
10.1 Global Dementia and Alzheimer’s Disease Treatment Market Size Forecast
10.2 Global Dementia and Alzheimer’s Disease Treatment Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Dementia and Alzheimer’s Disease Treatment Market Size Forecast by Country
10.2.3 Asia Pacific Dementia and Alzheimer’s Disease Treatment Market Size Forecast by Region
10.2.4 South America Dementia and Alzheimer’s Disease Treatment Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Dementia and Alzheimer’s Disease Treatment by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Dementia and Alzheimer’s Disease Treatment Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Dementia and Alzheimer’s Disease Treatment by Type (2025-2030)
11.1.2 Global Dementia and Alzheimer’s Disease Treatment Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Dementia and Alzheimer’s Disease Treatment by Type (2025-2030)
11.2 Global Dementia and Alzheimer’s Disease Treatment Market Forecast by Application (2025-2030)
11.2.1 Global Dementia and Alzheimer’s Disease Treatment Sales (Kilotons) Forecast by Application
11.2.2 Global Dementia and Alzheimer’s Disease Treatment Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings